✉news HealthMedicine first seen 3 d ago, last 2 d ago, peak #17
Off-the-Shelf CAR T Therapy Shows Early Promise in Progressive MS
Original: Off-the-Shelf CAR T Shows Early Signal in Progressive Multiple Sclerosis
An off-the-shelf CAR T-cell therapy has shown an early signal of effectiveness in treating progressive multiple sclerosis, according to reports in the pharmaceutical trade press. Unlike traditional CAR T treatments, which must be made from each patient's own cells, this approach uses donor-derived cells that can be manufactured in advance. Details on trial size and results remain limited, but the finding offers hope for a disease with few effective options.
Why now: CAR T-cell therapy moving into progressive multiple sclerosis would be a significant step for a condition with limited treatment options
CAR T-cell therapyprogressive multiple sclerosis
Rank over time, top of the chart is #1. 4 snapshots from 3 d ago to 2 d ago.
Evidence
- Off-the-Shelf CAR T Shows Early Signal in Progressive Multiple Sclerosis · The Medicine Maker
API: https://socialmediatrends-api.osmike.com/v1/trends/4609628